Medical devices, healthcare technology and the business of care
510(k) clearance · K254214

OOOPDS

Taiwan Main Orthopaedic Biotechnology Co., Ltd. · Decision date Sep 15, 2026

MEDTECHLEDGER EXPLANATIONK254214

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 09/15/2026 for OOOPDS, a 510(k) submitted by Taiwan Main Orthopaedic Biotechnology Co., Ltd. of Taichung, Taiwan. The submission, K254214, was received 12/29/2025 and reviewed under regulation 892.2050 in the radiology specialty, with classification product code LLZ and the device classification name System, Image Processing, Radiological. SESE in this context means the device was cleared for marketing; it is not a PMA approval.

The record identifies the submission as a traditional 510(k) that was not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The public record does not state which predicate device was used, what the substantial-equivalence basis was, or what the device's indications for use are; the summary field is empty. No clinical performance, imaging accuracy or patient-outcome data appear in the available text, so none can be reported here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 15, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254214
Regulatory pathway
510(k) premarket notification
Product code
LLZ
Decision code
SESE
Decision date
Sep 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Image Processing, Radiological.

Product code
LLZ
FDA device class
2

FDA decision timeline

  1. K254214 received

    Application receipt date recorded by FDA.

  2. K254214 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LLZ

Product / regulatory recordCompanyPathwayDecision dateSource
The Jacobs Institute510(k) clearanceNov 5, 2026FDA
Elevate Imaging, Inc.510(k) clearanceNov 4, 2026FDA
Canon Medical Informatics, Inc.510(k) clearanceOct 29, 2026FDA
Mim Software, Inc.510(k) clearanceOct 26, 2026FDA
Perception Vision Medical Technology Co., Ltd.510(k) clearanceOct 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Taiwan Main Orthopaedic Biotechnology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Taichung

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records